임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

28건 표시

2/3상모집 중단 (진행 중)· Pancreatic Ductal Adenocarcinoma
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
리드: BMS
상세 →NCT07076121
2/3상모집 중단 (진행 중)· Dyslipidaemia
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
리드: 아스트라제네카
상세 →NCT06834932
2/3상모집 중단 (진행 중)· HIV-1-infection
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
리드: 길리어드
상세 →NCT06532656
2/3상모집 중단 (진행 중)· HIV-1-Infection
Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed
리드: 길리어드
상세 →NCT06544733
2/3상모집 중단 (진행 중)· Head and Neck Squamous Cell Carcinoma
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
협력: 머크(MSD)
상세 →NCT06082167
2/3상모집 중단 (진행 중)· Hunter Syndrome
Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment
리드: 다케다
상세 →NCT06031259
2/3상모집 중단 (진행 중)· Non-small Cell Lung Cancer
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
리드: 리제네론
상세 →NCT05800015
2/3상모집 중단 (진행 중)· Advanced Non-Small Cell Lung Cancer
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
리드: 리제네론
상세 →NCT05785767
2/3상모집 중단 (진행 중)· Myelodysplastic Syndromes
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
리드: BMS
상세 →NCT05469737
2/3상모집 중단 (진행 중)· HIV-1-infection
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
리드: 길리어드
상세 →NCT05502341
2/3상모집 중단 (진행 중)· Spinal Muscular Atrophy (SMA)
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy
리드: 로슈
상세 →NCT05115110
2/3상모집 중단 (진행 중)· Gastric Cancer
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
협력: 일라이 릴리
상세 →NCT05002127
2/3상모집 중단 (진행 중)· AMD
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
리드: 애브비
상세 →NCT04704921
2/3상모집 중단 (진행 중)· Lung Cancer, Non-Small Cell
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy
리드: GSK
상세 →NCT04655976
2/3상모집 중단 (진행 중)· Breast Cancer
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
리드: 로슈
상세 →NCT04191499
2/3상모집 중단 (진행 중)· Hemophilia
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
리드: 사노피
상세 →NCT03974113
2/3상모집 중단 (진행 중)· HIV-1-infection
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
리드: 길리어드
상세 →NCT04150068
2/3상모집 중단 (진행 중)· Ulcerative Colitis
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
상세 →NCT04033445
2/3상모집 중단 (진행 중)· Warm Autoimmune Hemolytic Anemia
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
리드: 얀센(J&J)
상세 →NCT04119050
2/3상모집 중단 (진행 중)· Prostate Cancer
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
리드: 일라이 릴리
상세 →NCT03706365
2/3상모집 중단 (진행 중)· Crohn's Disease
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
상세 →NCT03466411
2/3상모집 중단 (진행 중)· Melanoma
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
리드: BMS
상세 →NCT03470922
2/3상모집 중단 (진행 중)· Non-Small Cell Lung Cancer
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
리드: 로슈
상세 →NCT03178552
2/3상모집 중단 (진행 중)· Colorectal Neoplasm
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
협력: 로슈
상세 →NCT02758951
2/3상모집 중단 (진행 중)· Acute Lymphoblastic Leukemia
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
협력: 암젠
상세 →NCT03117751
2/3상모집 중단 (진행 중)· HIV-1 Infection
Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1
리드: 길리어드
상세 →NCT02881320
2/3상모집 중단 (진행 중)· Acquired Immune Deficiency Syndrome (AIDS)
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV
리드: 길리어드
상세 →NCT02016924
2/3상모집 중단 (진행 중)· Alzheimers Disease
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
협력: 일라이 릴리, 로슈
상세 →NCT01760005

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.